OTRIVINE DUO SPRAY 1 FL MD 10 ML
9.16€
Symptomatic treatment of nasal congestion and rhinorrhoea associated with the common cold.
In stock
Description
Symptomatic treatment of nasal congestion and rhinorrhoea associated with the common cold.
Adults
1 spray in each nostril, maximum 3 times a day
Minimum interval between 2 doses: 6 h
Method of administration
Before using the sprayer for the first time or when the product has not been used for 9 days: spray a few times until you obtain an even spray.
1 ml contains 0.5 mg xylometazoline hydrochloride and 0.6 mg ipratropium bromide.
1 spray (approximately 140 microlitres) contains 70 micrograms of xylometazoline hydrochloride and 84 micrograms of ipratropium bromide.
Otrivine Duo should not be administered to children under 18 years of age due to insufficient data: – Hypersensitivity to the active substances or to any of the excipients mentioned in section 6.1.
– Known hypersensitivity to atropine or similar substances, e.g. hyoscyamine and scopolamine.
– After surgical procedures with possible penetration of the dura mater, e.g. transsphenoidal hypophysectomy or other transnasal procedures.
– In patients suffering from glaucoma.
– Patients suffering from rhinitis sicca.
Symptomatic treatment of nasal congestion accompanied by rhinorrhoea associated with a cold.
Nasal use.1 spray in each nostril, maximum 3 times a day. There should be an interval of at least 6 hours between two doses. Do not use more than 3 sprays in each nostril per day.
The duration of treatment should not exceed 7 days.
Otrivine Duo is a nasal decongestant based on xylometazoline (0.5mg/ml) and ipratropium bromide (0.6mg/ml).
Otrivine duo offers:
– the first and only simultaneous treatment for nasal congestion AND rhinorrhoea
– a rapid and long-lasting effect
– a good safety/efficacy ratio
For use from the age of 18.